Adaptive Radiotherapy Software Market Report 2026

Adaptive Radiotherapy Software Market Overview

• Adaptive Radiotherapy Software market size has reached to $0.7 billion in 2025 • Expected to grow to $1.36 billion in 2030 at a compound annual growth rate (CAGR) of 14% • Growth Driver: Rising Cancer Incidence Driving Demand For The Market Due To Increasing Patient Numbers And Need For Precision Treatment • Market Trend: Advancements In Ai-Driven Adaptive Radiotherapy For Enhanced Tumor Targeting • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Adaptive Radiotherapy Software Market?

Adaptive radiotherapy software refers to a specialized type of software used in radiation oncology that enables real-time or near-real-time modification of radiotherapy treatment plans based on changes in a patient’s anatomy, tumor size, or position during the course of treatment. It integrates imaging data (such as CT, MRI, or cone-beam CT) with treatment planning systems to optimize radiation dose delivery, improve tumor targeting, and minimize exposure to surrounding healthy tissues. The main component types of adaptive radiotherapy software are software and services. Software refers to the adaptive radiotherapy programs and platforms used for planning, monitoring, and delivering precise radiation treatments. These are deployed through on-premises and cloud-based. It is applied in areas such as prostate cancer, head and neck cancer, breast cancer, lung cancer, and others, serving end users including hospitals, cancer treatment centers, research institutes, and others.

What Is The Adaptive Radiotherapy Software Market Growth Forecast?

The adaptive radiotherapy software market size is expected to see rapid growth in the next few years. It will grow to $1.36 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to growing demand for personalized cancer treatment, integration of AI-driven treatment adaptation, rising adoption of cloud-based oncology software, increasing focus on reducing radiation toxicity, investments in advanced oncology infrastructure. Major trends in the forecast period include adaptive treatment planning, image-guided dose optimization, personalized radiation therapy protocols, workflow automation in radiation oncology, multi-modality imaging integration.

Global Adaptive Radiotherapy Software Market Segmentation

1) By Component: Software, Services 2) By Deployment Mode: On-Premises, Cloud-Based 3) By Application: Prostate Cancer, Head And Neck Cancer, Breast Cancer, Lung Cancer, Other Applications 4) By End User: Hospitals, Cancer Treatment Centers, Research Institutes, Other End-Users Subsegments: 1) By Software: Treatment Planning Software, Workflow Management Software, Imaging And Visualization Software 2) By Services: Implementation And Integration Services, Maintenance And Consulting Services, Training And Support Services

What Is The Driver Of The Adaptive Radiotherapy Software Market?

The rising number of cancer cases is expected to propel the growth of the adaptive radiotherapy software market going forward. Cancer cases refer to the number of individuals diagnosed with cancer in a specific population over a defined period. Cancer cases are rising among aging populations as longer lifespans lead to a higher accumulation of genetic mutations, increasing the risk of developing the disease. Adaptive radiotherapy software supports cancer treatment by adjusting radiation treatment in real time based on changes in tumor size, shape, and patient anatomy, improving precision, maximizing tumor targeting, and minimizing damage to healthy tissues. For instance, in February 2025, according to Cancer Australia, an Australia-based government agency, there were 4,641 new pancreatic cancer cases in 2024, with 2,414 in males and 2,227 in females. Therefore, the rising number of cancer cases is driving the growth of the adaptive radiotherapy software industry.

Key Players In The Global Adaptive Radiotherapy Software Market

Major companies operating in the adaptive radiotherapy software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., United Imaging Healthcare Co. Ltd., Brainlab AG, Accuray Incorporated, RaySearch Laboratories AB, ViewRay Inc., C-RAD AB, Standard Imaging Inc., LAP GmbH Laser Applikationen, Oncology Systems Limited, DOSIsoft SA, Mirada Medical Ltd., Limbus AI, MagnetTx Oncology Solutions Ltd., Spectronic Medical AB, Akesis Inc.

Global Adaptive Radiotherapy Software Market Trends and Insights

Major companies operating in the adaptive radiotherapy software market are focusing on developing technological advancements such as AI-powered, adaptive CT-Linac to enhance real-time tumor targeting, improve treatment precision, and optimize patient outcomes. AI-powered, adaptive CT-Linac refers to a radiation therapy system that combines computed tomography (CT) imaging with a linear accelerator (Linac), using artificial intelligence (AI) to adapt and optimize radiation delivery in real time based on changes in tumor size, shape, and position during treatment. For instance, in May 2024, Elekta AB, a Sweden-based medication company, launched Evo, designed for precise and efficient radiotherapy treatments. It is designed to deliver highly personalized and precise cancer radiation therapy. It offers advanced AI-enhanced imaging, enabling clinicians to visualize tumors with exceptional clarity and adapt treatments in real time or between sessions. Evo aims to improve treatment accuracy, reduce side effects, and enhance patients’ quality of life, while allowing clinics to adopt innovative technology at their own pace.

What Are Latest Mergers And Acquisitions In The Adaptive Radiotherapy Software Market?

In April 2024, GE Healthcare Technologies Inc., a US-based medical diagnostics company, acquired MIM Software Inc. for an undisclosed amount. With this acquisition, GE Healthcare Technologies Inc. aims to strengthen its precision care strategy by integrating MIM Software’s AI-powered imaging analytics and digital workflow solutions to deliver more precise, connected, and efficient patient care across multiple disease areas. MIM Software Inc. is a US-based software company that offers adaptive radiotherapy software.

Regional Outlook

North America was the largest region in the adaptive radiotherapy software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Adaptive Radiotherapy Software Market?

The adaptive radiotherapy software market consists of revenues earned by entities by providing services such as imaging data processing services, radiation dose adjustment services, real-time monitoring services, clinical workflow customization services, and regulatory compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The adaptive radiotherapy software market also includes sales of imaging systems, treatment planning systems, verification tools, deformable registration tools, oncology information systems, and dose tracking systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.